Benzinga | Aug 10, 2020 07:15AM EDT

Neos Therapeutics Q2 EPS $(0.11) Beats $(0.13) Estimate, Sales $13.11M Beat $12.17M Estimate

Neos Therapeutics (NASDAQ:NEOS) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 37.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $13.11 million which beat the analyst consensus estimate of $12.17 million by 7.75 percent. This is a 16.17 percent decrease over sales of $15.64 million the same period last year.